China, India
I-Diagnostic imaging isindisa kanjani izimpilo ezimpini eziningi ze-Myeloma?
Ufuna ukwazi ukuthi indlela yezokwelapha isindisa kanjani izimpilo zeziguli eziningi ze-myeloma? Funda ibhulogi yethu ukuze ufunde kabanzi mayelana nale nqubo esindisa impilo! Ake sivule ikhasi lomdlavuza ndawonye. Indaba yakho yethemba iqala lapha. Isihogo..
i-anti-BCMA, I-BCMA CAR-T, i-chimeric antigen receptor T cell therapy, China, I-Immune thrombocytopenia, I-ITP
I-Anti-BCMA CAR T-Cell therapy therapy trials for relapse/refractory Immune thrombocytopenia(R/R ITP)
Mashi 2023: I-Immune thrombocytopenia (ITP) wukuphazamiseka okungaholela ekulimazeni okulula noma ngokweqile nokopha. Cishe izingxenye ezimbili kwezintathu zeziguli zithola ukukhululeka ngemva/ngesikhathi sokwelashwa komugqa wokuqala. Nokho, enye ingxenye o..
biotechnology, Ukwelashwa kwe-CAR - T Cell, ISIMOTO SEMOTO, Ukwelashwa kweCAR, China, ukukhushulwa kwezimali, I-Oricell Therapeutics
I-Oricell inyusa u-$45M USD owengeziwe ukuze inwebise ukwelashwa kwayo kwe-CAR T-Cell iye e-United States
Ngomhla zingama-23 kuNdasa 2023: Izindlela zokwelapha zomdlavuza ezitholakala ngaphambi kwesikhathi kanye nesigaba sokuqala somdlavuza ezithuthukiswa yi-Shanghai biotech Oricell bathole enye imali eyizigidi ezingama- $ 45, kumemezele inkampani ngoLwesibili. Kulandela umbukiso e-AS..
Beijing, I-CARTITUDE-4, I-CARYKTI, China, i-ciltacabtagene autoleucel, Izivivinyo zemitholampilo, I-Legend biotech, i-myeloma eminingi ephikisayo, Shanghai
I-Legend Biotech Imemezela Isigaba sesi-3 I-CARTITUDE-4 Study ye-CARVYKTI®(ciltacabtagene autoleucel) Isifinyelele Isiphetho Sayo Esiyinhloko Ekwelapheni Iziguli ezine-Myeloma Ephindaphindekayo neRefractory
JANUARY 27, 2023—I-Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), inkampani yomhlaba wonke ye-biotechnology ethuthukisa, ekhiqiza futhi ethengisa izindlela zokwelapha ezinoveli ukwelapha izifo ezisongela ukuphila, imemezele namuhla ukuthi ..
Beijing, biotechnology, Ukwelashwa kwamaseli, Ukwelashwa ngamaselula, China, I-Cilta-Cel, i-ciltacabtagene autoleucel, I-Legend biotech
I-Legend Biotech Imemezela Ukwamukelwa Kwesicelo Sayo Esisha Sezidakamizwa se-Ciltacabtagene Autoleucel (Cilta-Cel) e-China
I-SOMERSET, NJ—JANUARY 2, 2023— I-Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), inkampani yomhlaba wonke ye-biotechnology ethuthukisa, ekhiqiza futhi ethengisa izindlela zokwelapha ezintsha zokwelapha izifo ezisongela ukuphila, ngonyaka.
China, Izivivinyo zemitholampilo, i-hepatocellular carcinoma, I-JW Therapeutics, Shanghai
I-JW Therapeutics Imemezela Ukuqaliswa Kwezifundo Zomtholampilo ze-JWATM214 Ezigulini ezine-Advanced Hepatocellular Carcinoma
I-SHANGHAI, ECHINA, Februwari 28, 2023 - I-JW Therapeutics (HKEX: 2126), inkampani ezimele nentsha ye-biotechnology egxile ekuthuthukiseni, ekukhiqizeni nasekuthengiseni imikhiqizo ye-cell immunotherapy, imemezele init.
I-American Society of Hematology, I-Carteyva, China, I-JW Therapeutics, i-relmacabtagene autoleucel
I-JW Therapeutics Yethula Idatha Yakamuva Yomtholampilo ku-Carteyva® ku-Follicular Lymphoma kanye ne-Mantle Cell Lymphoma eMhlanganweni Wonyaka wama-64 we-ASH
E-SHANGHAI, ECHINA, Disemba 12, 2022 Inkampani ezimele futhi enobuhlakani be-biotechnology ebizwa ngokuthi i-JW Therapeutics (HKEX: 2126) igxile ekuthuthukiseni, ekukhiqizeni, nasekudayiseni imikhiqizo ye-cell immunotherapy. Ku-64th American Society..
Ukwelashwa kwamaseli, China, I-JW Therapeutics, Shanghai
I-JW Therapeutics Imemezela Ukuthi Izidakamizwa Zayo Ze-Cell Immunotherapy Zihlomulise Ngempumelelo Iziguli Ezingama-300
I-SHANGHAI, ECHINA, Novemba 9, 2022 - I-JW Therapeutics (HKEX: 2126), inkampani ezimele nentsha ye-biotechnology egxile ekuthuthukiseni, ekukhiqizeni, nasekuthengiseni imikhiqizo ye-cell immunotherapy, imemezele ukuthi kusukela ngo-N.
2 amashumi ayisikhombisa bio, China, immunotherapy, I-JW Therapeutics, lobambiswano
I-JW Therapeutics kanye ne-2seventy bio Memezela Ubambiswano Lwesu Lokusheshisa Ucwaningo Nokuthuthukiswa Kwe-T-cell-based Immunotherapies
I-SHANGHAI, CHINA kanye ne-CAMBRIDGE, MASSACHUSETTS, US, Okthoba 27, 2022 - I-JW Therapeutics (HKEX: 2126), inkampani ezimele nentsha ye-biotechnology egxile ekuthuthukiseni, ekukhiqizeni nasekuthengiseni i-cell immunotherap.
China, I-Enhertu, HER 2 positive
I-Enhertu igunyazwe e-China ezigulini ezinomdlavuza webele we-HER2-positive metastatic
Feb 2023: I-Enhertu (trastuzumab deruxtecan) evela ku-AstraZeneca kanye ne-Daiichi Sankyo igunyazwe njenge-monotherapy yokwelapha iziguli ezikhulile ezinomdlavuza webele ongapholi noma one-metastatic HER2-positive ezithole ..